THC Biomed Intl Ltd.
THC
CNSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 281.80K | 451.80K | 424.90K | 522.20K | 386.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 281.80K | 451.80K | 424.90K | 522.20K | 386.50K |
| Cost of Revenue | 555.20K | 729.00K | 288.90K | 987.50K | 544.90K |
| Gross Profit | -273.50K | -277.20K | 136.00K | -465.30K | -158.50K |
| SG&A Expenses | 269.10K | 290.60K | 214.60K | 434.50K | 248.20K |
| Depreciation & Amortization | 141.70K | 158.20K | 159.50K | 189.50K | 181.50K |
| Other Operating Expenses | -- | -- | -- | 400.00 | 4.60K |
| Total Operating Expenses | 966.00K | 1.18M | 663.00K | 1.61M | 979.20K |
| Operating Income | -684.30K | -726.00K | -238.10K | -1.09M | -592.80K |
| Income Before Tax | -690.50K | -736.00K | -249.10K | -1.10M | -103.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -690.50K | -736.00K | -249.10K | -1.10M | -103.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -690.50K | -736.00K | -249.10K | -1.10M | -103.50K |
| EBIT | -684.30K | -726.00K | -238.10K | -1.09M | -592.80K |
| EBITDA | -542.60K | -567.80K | -126.90K | -829.20K | -533.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 163.94M | 163.94M | 163.94M | 163.94M | 163.94M |
| Average Diluted Shares Outstanding | 163.94M | 163.94M | 163.94M | 163.94M | 163.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |